TY - JOUR
T1 - Prevalence and Physical and Mental Health Patterns of Rheumatic and Musculoskeletal Diseases in Portugal
T2 - Results from Epireumapt, A National Health Survey
AU - Branco, J.
AU - Rodrigues, A.M.
AU - Gouveia, N.
AU - Pereira, L.
AU - Eusébio, M.
AU - Ramiro, S.
AU - Machado, Pedro
AU - Mourão, A.F.
AU - Silva, Inês Gomes da
AU - Laires, P A
AU - Sepriano, A.
AU - Araújo, F.
AU - Gonçalves, Sónia P.
AU - Coelho, P.S.
AU - Tavares, Viviana
AU - Cerol, Jorge
AU - Mendes, J.M.
AU - Carmona, Loreto
AU - Canhão, H.
PY - 2015
Y1 - 2015
N2 - Background Rheumatic and musculoskeletal diseases (MSKD) are a prevalent leading cause of disability and consume a large amount of healthcare and social resources. MSKD have been associated with low levels of physical and mental health in other countries.Objectives To estimate the national prevalence of hand, knee and hip osteoarthritis (OA), low back pain (LBP), rheumatoid arthritis (RA), fibromyalgia (FM), gout, spondyloarthritis (SpA), periarticular disease (PD) systemic lupus erythematosus (SLE), polymyalgia rheumatica (PMR) and osteoporosis (OP)) in the adult Portuguese population; to compare physical and mental health between participants with and without MSKD.Methods EpiReumaPt is a national health survey conducted from Sep'2011 to Dec'2013, which involved a three-stage approach. First, 10661 adult subjects were randomly selected. Trained interviewers undertook structured face-to-face questionnaires in participant's households that included a screening for MSKD, and the EQ5D and HAQ. Secondly, all participants screened positive for at least one MSKD plus 20% of individuals with no rheumatic complaints were invited to be seen by a rheumatologist at the local Primary Care Center for a structured evaluation. Finally, a team of 3 experienced rheumatologists revised all the clinical data and confirmed the diagnoses according to previously validated criteria. Estimates were computed as weighted proportions, in order to take into account the sampling design.Results Prevalence of MSKD in the adult Portuguese population is presented in Table 1 with 95% CI. After adjustment, subjects with RMD had significantly lower EQ5D scores (β=-0.09; p
AB - Background Rheumatic and musculoskeletal diseases (MSKD) are a prevalent leading cause of disability and consume a large amount of healthcare and social resources. MSKD have been associated with low levels of physical and mental health in other countries.Objectives To estimate the national prevalence of hand, knee and hip osteoarthritis (OA), low back pain (LBP), rheumatoid arthritis (RA), fibromyalgia (FM), gout, spondyloarthritis (SpA), periarticular disease (PD) systemic lupus erythematosus (SLE), polymyalgia rheumatica (PMR) and osteoporosis (OP)) in the adult Portuguese population; to compare physical and mental health between participants with and without MSKD.Methods EpiReumaPt is a national health survey conducted from Sep'2011 to Dec'2013, which involved a three-stage approach. First, 10661 adult subjects were randomly selected. Trained interviewers undertook structured face-to-face questionnaires in participant's households that included a screening for MSKD, and the EQ5D and HAQ. Secondly, all participants screened positive for at least one MSKD plus 20% of individuals with no rheumatic complaints were invited to be seen by a rheumatologist at the local Primary Care Center for a structured evaluation. Finally, a team of 3 experienced rheumatologists revised all the clinical data and confirmed the diagnoses according to previously validated criteria. Estimates were computed as weighted proportions, in order to take into account the sampling design.Results Prevalence of MSKD in the adult Portuguese population is presented in Table 1 with 95% CI. After adjustment, subjects with RMD had significantly lower EQ5D scores (β=-0.09; p
U2 - 10.1136/annrheumdis-2015-eular.3854
DO - 10.1136/annrheumdis-2015-eular.3854
M3 - Article
SN - 0003-4967
VL - 74
SP - 86
JO - Annals of the rheumatic diseases
JF - Annals of the rheumatic diseases
IS - Suppl 2
ER -
